EPL clears CCI hurdle for Indovida India merger
The Competition Commission of India approved the absorption of Indovida India into EPL. This removes a regulatory condition precedent for the deal.
— 1 earlier story on EPL Ltd. →What's new
- CCI issued a no-objection for the merger of Indovida India into EPL.
- The deal requires further statutory and regulatory approvals.
- The scheme was originally approved by the EPL board on March 29, 2026.
Why this matters
Regulatory clearance is a prerequisite for the merger. This approval reduces deal execution risk. The market expected this step, but the formal sign-off brings the transaction closer to completion.
What we're watching
- The release of the detailed CCI order.
- Updates on remaining statutory and regulatory approvals.
- Any disclosure regarding the final timeline for the merger.
The full read
EPL secured a no-objection from the Competition Commission of India for its proposed merger with Indovida India Private Limited. The approval, granted under Section 31(1) of the Competition Act, follows the board's initial approval on March 29, 2026. The transaction involves the absorption of Indovida India into EPL through a court-sanctioned process under Sections 230-232 of the Companies Act.
It is a routine step.
While the detailed order is pending, the clearance removes a condition precedent for the ₹7,014 crore market-cap packaging group, which had already seen the market price in this progression, meaning the news lacks a surprise element and simply confirms the deal is proceeding as planned.
Questions answered
- What does the CCI approval mean for the merger?
- It clears a regulatory condition precedent for the absorption of Indovida India into EPL. The merger still requires further statutory and regulatory approvals before it can be finalized.
- When was the merger first announced?
- The EPL board approved the scheme of amalgamation on March 29, 2026.
- What is the legal process for this merger?
- The companies are proceeding through a court-sanctioned process under Sections 230-232 of the Companies Act.
- Does this filing change the deal terms?
- No. The filing does not disclose any changes to the deal terms or financial impact of the merger.
Story so far
All notes on EPL →- 27 May 2026 · 5:46 PM IST EPL clears CCI hurdle for Indovida India merger
- 7d ago EPL's transcript: Cost pass-through confidence, Indovida merger on track